Cargando…
Amplicon Deep Sequencing Reveals Multiple Genetic Events Lead to Treatment Failure with Atovaquone-Proguanil in Plasmodium falciparum
Atovaquone-proguanil (AP) is used as treatment for uncomplicated malaria, and as a chemoprophylactic agent against Plasmodium falciparum. Imported malaria remains one of the top causes of fever in Canadian returning travelers. Twelve sequential whole-blood samples before and after AP treatment failu...
Autores principales: | Castañeda-Mogollón, Daniel, Toppings, Noah B., Kamaliddin, Claire, Lang, Raynell, Kuhn, Susan, Pillai, Dylan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269153/ https://www.ncbi.nlm.nih.gov/pubmed/37154745 http://dx.doi.org/10.1128/aac.01709-22 |
Ejemplares similares
-
Plasmodium falciparum Malaria and Atovaquone-Proguanil Treatment Failure
por: Durand, Rémy, et al.
Publicado: (2008) -
Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria
por: Blanshard, Andrew, et al.
Publicado: (2021) -
Comparative Analysis of Plasmodium falciparum Genotyping via SNP Detection, Microsatellite Profiling, and Whole-Genome Sequencing
por: Kanai, Mariko, et al.
Publicado: (2022) -
Plasmodium falciparum GCN5 plays a key role in regulating artemisinin resistance-related stress responses
por: Lucky, Amuza Byaruhanga, et al.
Publicado: (2023) -
The Mu Subunit of Plasmodium falciparum Clathrin-Associated Adaptor Protein 2 Modulates In Vitro Parasite Response to Artemisinin and Quinine
por: Henriques, Gisela, et al.
Publicado: (2015)